{
  "_link": {
    "uuid": "lp-27e89278-0674-e14a-97e0-2fffdaf2aaec",
    "version": 1,
    "contentHash": "8f7b439d",
    "title": "I can explain the advantages of CRISPR-Cas9 over restriction enzymes and earlier gene editing methods",
    "generatedAt": "2026-02-10T12:10:00.000Z"
  },
  "toLevel2": [
    {"type":"MC","question":"Why is CRISPR-Cas9 more precise than restriction enzymes when cutting DNA?","correct":"The gRNA is 20 nucleotides long, targeting a unique sequence, while restriction enzymes recognise only 4-6 nucleotide sites that occur many times","correctExplanation":"A 20-nucleotide sequence is statistically likely to occur only once in an entire genome, while short restriction enzyme sites appear hundreds of times.","distractors":[{"answer":"CRISPR cuts faster than restriction enzymes","explanation":"Speed is not the key advantage; precision of targeting is the main difference."},{"answer":"Restriction enzymes cannot cut double-stranded DNA","explanation":"Restriction enzymes do cut double-stranded DNA; the issue is that they cut at many sites."},{"answer":"CRISPR uses heat shock to improve cutting accuracy","explanation":"Heat shock is used in bacterial transformation, not in CRISPR cutting."}]},
    {"type":"MC","question":"How many nucleotides long is the guide RNA used in CRISPR-Cas9?","correct":"20 nucleotides","correctExplanation":"The gRNA sequence is typically 20 nucleotides long, providing high specificity for targeting a single genomic location.","distractors":[{"answer":"4 nucleotides","explanation":"4 nucleotides would be too short for specific targeting; restriction enzymes use 4-6 nucleotide sites."},{"answer":"6 nucleotides","explanation":"6 nucleotides is the length of many restriction enzyme recognition sites, not the CRISPR gRNA."},{"answer":"100 nucleotides","explanation":"The targeting portion of the gRNA is about 20 nucleotides, not 100."}]},
    {"type":"MC","question":"What is a disadvantage of earlier viral gene therapy methods compared to CRISPR-Cas9?","correct":"Viral methods insert genes at random locations, risking disruption of other important genes","correctExplanation":"Earlier gene therapy used viruses to deliver genes, but the insertion site was unpredictable, sometimes disrupting tumour suppressor genes or other essential sequences.","distractors":[{"answer":"Viral methods cannot deliver genes into cells","explanation":"Viruses can deliver genes into cells; the issue is that insertion occurs at random locations."},{"answer":"Viral methods are more precise than CRISPR","explanation":"Viral gene therapy is less precise because it inserts at random locations; CRISPR targets specific sites."},{"answer":"Viral methods only work on bacteria","explanation":"Viral gene therapy works on human cells; the issue is random insertion, not host range."}]},
    {"type":"MC","question":"Which of the following is an advantage of CRISPR-Cas9 as a gene editing tool?","correct":"It is cheap, easy to use and highly accurate","correctExplanation":"CRISPR-Cas9 is significantly cheaper and simpler than earlier gene editing methods like TALENs and ZFNs, while maintaining high accuracy.","distractors":[{"answer":"It requires expensive specialised equipment unavailable to most labs","explanation":"CRISPR is notable for being accessible and affordable for most research laboratories."},{"answer":"It can only edit bacterial genomes","explanation":"CRISPR can edit genomes of any organism, including plants, animals and humans."},{"answer":"It always requires PCR to function","explanation":"CRISPR does not require PCR; it uses sgRNA and Cas9 for genome editing."}]},
    {"type":"MC","question":"A restriction enzyme with a 6-base recognition site might cut human genomic DNA at how many locations?","correct":"Hundreds of locations throughout the genome","correctExplanation":"A 6-base sequence occurs statistically every ~4000 base pairs, meaning it would appear thousands of times across the 3 billion base pair human genome.","distractors":[{"answer":"Exactly one location in the genome","explanation":"A 6-base site is too short to be unique; it occurs many times across the genome."},{"answer":"No locations because human DNA differs from bacterial DNA","explanation":"Restriction enzymes cut any DNA with matching recognition sites, regardless of origin."},{"answer":"Only at VNTR regions","explanation":"Restriction enzymes cut at any matching recognition site, not only at VNTRs."}]},
    {"type":"Cloze","prompt":"Complete the sentence comparing CRISPR and restriction enzymes.","sentence":"CRISPR-Cas9 uses a {{blank:1}}-nucleotide gRNA for targeting, compared to the {{blank:2}}-nucleotide recognition sites of restriction enzymes, making CRISPR far more precise.","blanks":{"1":{"correct":"20","correctExplanation":"The gRNA targeting sequence is 20 nucleotides long, providing very high specificity.","distractors":[{"answer":"4","explanation":"4 nucleotides is the length of the shortest restriction enzyme sites, not the CRISPR gRNA."},{"answer":"6","explanation":"6 nucleotides is typical for restriction enzyme sites; the CRISPR gRNA is 20 nucleotides."}]},"2":{"correct":"4-6","correctExplanation":"Most restriction enzymes recognise sequences of 4-6 nucleotides, which are too short for unique genome targeting.","distractors":[{"answer":"20","explanation":"20 nucleotides is the gRNA length; restriction enzymes recognise 4-6 nucleotide sequences."},{"answer":"100","explanation":"Restriction enzyme recognition sites are 4-6 nucleotides, not 100."}]}}},
    {"type":"Cloze","prompt":"Complete the sentence about the advantages of CRISPR.","sentence":"Unlike earlier viral gene therapy methods, CRISPR-Cas9 can target an {{blank:1}} location on the genome, avoiding the risk of {{blank:2}} other genes.","blanks":{"1":{"correct":"exact","correctExplanation":"CRISPR targets a precise location determined by the sgRNA sequence, unlike random viral insertion.","distractors":[{"answer":"random","explanation":"Random targeting is the problem with older methods; CRISPR's advantage is exact targeting."},{"answer":"approximate","explanation":"CRISPR targets exact locations through 20-nucleotide complementarity, not approximate ones."}]},"2":{"correct":"disrupting","correctExplanation":"Random insertion by viral vectors could disrupt essential genes; CRISPR avoids this by targeting specific sites.","distractors":[{"answer":"amplifying","explanation":"The risk is disruption of other genes, not their amplification."},{"answer":"expressing","explanation":"The concern is disrupting genes, not expressing them."}]}}},
    {"type":"Cloze","prompt":"Complete the sentence about CRISPR's accessibility.","sentence":"CRISPR-Cas9 has revolutionised genetic engineering because it is {{blank:1}}, easy to use, and highly {{blank:2}} compared to older methods.","blanks":{"1":{"correct":"cheap","correctExplanation":"CRISPR is significantly less expensive than earlier genome editing techniques like TALENs and ZFNs.","distractors":[{"answer":"expensive","explanation":"CRISPR is notable for being cheap, not expensive, compared to older techniques."},{"answer":"slow","explanation":"CRISPR is efficient and relatively fast, not slow."}]},"2":{"correct":"accurate","correctExplanation":"The 20-nucleotide gRNA provides high accuracy in targeting specific genomic locations.","distractors":[{"answer":"random","explanation":"CRISPR is precise, not random; the gRNA ensures accurate targeting."},{"answer":"unreliable","explanation":"CRISPR is highly reliable and accurate for genome editing."}]}}},
    {"type":"TF","question":"CRISPR-Cas9 can target a single specific location in a genome, while restriction enzymes cut at multiple sites.","correct":"True","correctExplanation":"The 20-nucleotide gRNA provides enough specificity to target a unique site, while short restriction enzyme recognition sequences occur many times across a genome.","distractors":[{"answer":"False","explanation":"This is a key advantage of CRISPR: its 20-nucleotide targeting provides single-site specificity."}]},
    {"type":"TF","question":"Restriction enzymes are more precise than CRISPR-Cas9 for genome editing.","correct":"False","correctExplanation":"CRISPR-Cas9 is more precise because its 20-nucleotide gRNA targets a unique sequence, while restriction enzymes cut at multiple sites throughout the genome.","distractors":[{"answer":"True","explanation":"Restriction enzymes have shorter recognition sites (4-6 nucleotides) that occur many times in a genome, making them less precise."}]}
  ],
  "toLevel3": [
    {"type":"MC","question":"Explain why a 20-nucleotide sequence is more likely to be unique in a genome than a 6-nucleotide sequence.","correct":"Each additional nucleotide multiplies the possible combinations by 4, so a 20-nucleotide sequence has 4²⁰ (over a trillion) possible combinations versus 4⁶ (4096) for a 6-nucleotide sequence","correctExplanation":"The number of possible sequences increases exponentially with length. A 20-nucleotide sequence is astronomically more specific than a 6-nucleotide one.","distractors":[{"answer":"Longer sequences are always found more frequently in genomes","explanation":"Longer specific sequences are found less frequently because there are more possible combinations."},{"answer":"The number of possible sequences does not change with length","explanation":"Each additional nucleotide multiplies possibilities by 4; length greatly affects uniqueness."},{"answer":"6-nucleotide sequences never appear in genomes","explanation":"6-nucleotide sequences appear frequently; they are too common for unique targeting."}]},
    {"type":"MC","question":"How does the precision of CRISPR-Cas9 reduce the risk of unintended consequences compared to viral gene therapy?","correct":"CRISPR targets a specific site chosen by the scientist, while viral vectors insert genes at random locations that might disrupt essential genes","correctExplanation":"Random insertion by viruses has caused cancer in early gene therapy trials. CRISPR's targeted approach greatly reduces this risk.","distractors":[{"answer":"CRISPR never causes any unintended consequences","explanation":"CRISPR can have off-target effects, but these are much less likely than random viral insertion."},{"answer":"Viral gene therapy is more precise because viruses naturally know where to insert genes","explanation":"Most viral vectors insert randomly; they do not target specific beneficial locations."},{"answer":"CRISPR and viral gene therapy have identical precision","explanation":"CRISPR is significantly more precise because it targets a specific 20-nucleotide sequence."}]},
    {"type":"MC","question":"Why did earlier gene editing methods like ZFNs and TALENs fail to achieve the same widespread adoption as CRISPR?","correct":"ZFNs and TALENs require complex protein engineering for each new target, while CRISPR only needs a new RNA sequence","correctExplanation":"Designing new ZFNs or TALENs requires engineering custom proteins, which is time-consuming and expensive. CRISPR only requires designing a short RNA sequence.","distractors":[{"answer":"ZFNs and TALENs cannot cut DNA","explanation":"Both can cut DNA, but the protein design process is much more complex than designing an RNA guide."},{"answer":"CRISPR was invented first and became established before ZFNs","explanation":"ZFNs and TALENs were developed before CRISPR; CRISPR's simplicity led to its wider adoption."},{"answer":"ZFNs and TALENs only work on bacterial genomes","explanation":"Both work on various genomes; the issue is the complexity and cost of designing each new construct."}]},
    {"type":"MC","question":"A scientist needs to make a single precise cut in the human genome to correct a disease mutation. Why would CRISPR-Cas9 be preferred over using a restriction enzyme?","correct":"CRISPR can target the exact mutation site with its 20-nucleotide gRNA, while the restriction enzyme would cut at hundreds of matching sites across the genome","correctExplanation":"The restriction enzyme cannot make a single cut because its short recognition site occurs throughout the genome. CRISPR's longer target ensures a single precise cut.","distractors":[{"answer":"Restriction enzymes cannot cut human DNA","explanation":"Restriction enzymes can cut any DNA with matching recognition sites, including human DNA."},{"answer":"CRISPR is slower but there is no alternative","explanation":"CRISPR is preferred because of its precision, not because there are no alternatives."},{"answer":"The restriction enzyme would be more precise for this task","explanation":"Restriction enzymes are less precise because they cut at multiple locations."}]},
    {"type":"MC","question":"What does it mean when CRISPR-Cas9 is described as 'programmable'?","correct":"Scientists can target any DNA sequence by simply changing the gRNA sequence, without needing to engineer a new protein","correctExplanation":"The programmability of CRISPR comes from the ease of designing new gRNA sequences. Changing the 20-nucleotide guide allows targeting any new location.","distractors":[{"answer":"CRISPR requires computer programming to function","explanation":"Programmable refers to the ability to retarget by changing the RNA sequence, not computer coding."},{"answer":"Cas9 can be programmed to cut at different temperatures","explanation":"Programmable means retargetable through gRNA design, not temperature-dependent."},{"answer":"CRISPR only works when connected to a computer","explanation":"CRISPR is a molecular tool; programmable refers to the ease of changing the target sequence."}]},
    {"type":"MC","question":"Explain why the cost reduction of CRISPR compared to earlier methods is significant for the field of genetics.","correct":"Lower costs allow more researchers worldwide to access genome editing, accelerating research and democratising the technology","correctExplanation":"When a technology is cheap, it becomes accessible to labs in universities, developing countries and small companies, not just well-funded institutions.","distractors":[{"answer":"Cost has no effect on who can use the technology","explanation":"Cost is a major barrier to technology adoption; cheaper tools reach more researchers."},{"answer":"CRISPR is more expensive than all earlier methods","explanation":"CRISPR is significantly cheaper than ZFNs, TALENs and other earlier editing methods."},{"answer":"Only the cost of restriction enzymes matters for genetic research","explanation":"The cost of the editing tool itself determines accessibility of genome editing."}]},
    {"type":"Cloze","prompt":"Complete the sentence about programmability.","sentence":"CRISPR is described as programmable because changing the {{blank:1}} sequence retargets Cas9 to any new location, unlike ZFNs and TALENs which require redesigning a new {{blank:2}} for each target.","blanks":{"1":{"correct":"gRNA","correctExplanation":"Designing a new gRNA sequence is all that's needed to change the CRISPR target.","distractors":[{"answer":"Cas9","explanation":"Cas9 does not change; it is the gRNA that is redesigned for new targets."},{"answer":"PAM","explanation":"PAM sequences are fixed in the genome; the gRNA is what scientists design."}]},"2":{"correct":"protein","correctExplanation":"ZFNs and TALENs require engineering new DNA-binding proteins for each target, which is complex and expensive.","distractors":[{"answer":"RNA","explanation":"ZFNs and TALENs use custom proteins, not RNA, for targeting. CRISPR's RNA-based targeting is what makes it simpler."},{"answer":"plasmid","explanation":"The bottleneck for ZFNs and TALENs is protein engineering, not plasmid construction."}]}}},
    {"type":"Cloze","prompt":"Complete the sentence comparing cutting specificity.","sentence":"A restriction enzyme with a 6-nucleotide recognition site may cut at {{blank:1}} of locations across the genome, while CRISPR's 20-nucleotide gRNA is designed to match only {{blank:2}} specific site.","blanks":{"1":{"correct":"hundreds","correctExplanation":"Short recognition sequences appear many times in a large genome, causing cuts at multiple locations.","distractors":[{"answer":"zero","explanation":"The restriction enzyme would find many matching sites, not zero."},{"answer":"one","explanation":"A 6-nucleotide site is too short to be unique; it appears hundreds of times."}]},"2":{"correct":"one","correctExplanation":"A 20-nucleotide sequence is long enough to be statistically unique in a genome, enabling a single precise cut.","distractors":[{"answer":"hundreds","explanation":"A 20-nucleotide sequence is extremely specific and typically matches only one site."},{"answer":"thousands","explanation":"The precision of the 20-nucleotide guide means it targets one location, not thousands."}]}}},
    {"type":"Cloze","prompt":"Complete the sentence about viral gene therapy risks.","sentence":"Earlier viral gene therapy methods inserted genes at {{blank:1}} locations in the genome, which sometimes disrupted tumour {{blank:2}} genes, causing cancer in treated patients.","blanks":{"1":{"correct":"random","correctExplanation":"Viral vectors insert their genetic cargo at unpredictable locations in the host genome.","distractors":[{"answer":"specific","explanation":"Viral insertion is random, not specific; this unpredictability is the risk."},{"answer":"precise","explanation":"Viral insertion is not precise; CRISPR was developed partly to overcome this limitation."}]},"2":{"correct":"suppressor","correctExplanation":"Random insertion into tumour suppressor genes eliminated their protective function, leading to cancer in some patients.","distractors":[{"answer":"promoter","explanation":"Tumour suppressor genes were disrupted; promoters regulate gene expression but are not the genes disrupted here."},{"answer":"resistance","explanation":"The genes disrupted were tumour suppressors, not resistance genes."}]}}},
    {"type":"TF","question":"ZFNs and TALENs require engineering new proteins for each target, while CRISPR only needs a new RNA sequence.","correct":"True","correctExplanation":"This difference in design complexity is a key reason CRISPR has been more widely adopted than earlier genome editing methods.","distractors":[{"answer":"False","explanation":"ZFNs and TALENs do require custom protein design, which is more complex and expensive than designing a new gRNA for CRISPR."}]}
  ],
  "toLevel4": [
    {"type":"MC","question":"A hospital has limited funding and needs to establish a genome editing program. Compare the practicality of using CRISPR-Cas9 versus TALENs for this purpose.","correct":"CRISPR is more practical because it is cheaper to design new targets (only new RNA sequences needed), faster to implement, and requires less specialised expertise","correctExplanation":"CRISPR's low cost, simplicity and RNA-based retargeting make it ideal for resource-limited settings compared to the expensive protein engineering required for TALENs.","distractors":[{"answer":"TALENs are better because they are more widely available commercially","explanation":"CRISPR is more commercially available and accessible than TALENs."},{"answer":"Both methods have identical costs and complexity","explanation":"CRISPR is significantly cheaper and simpler to implement than TALENs."},{"answer":"The hospital should use restriction enzymes instead of either method","explanation":"Restriction enzymes cannot perform precise genome editing at single sites."}]},
    {"type":"MC","question":"A researcher needs to edit genes in three different organisms — a bacterium, a plant and a human cell line. How does CRISPR's programmability benefit this project?","correct":"The same Cas9 protein works in all organisms; only the gRNA needs to be redesigned for each target, saving time and cost","correctExplanation":"CRISPR's universal applicability means the same system works across species. Only the 20-nucleotide gRNA changes, making multi-organism projects efficient.","distractors":[{"answer":"Different Cas9 proteins must be designed for each organism","explanation":"The same Cas9 protein functions across organisms; only the gRNA changes."},{"answer":"CRISPR can only edit one organism type per experiment","explanation":"CRISPR can target any organism by changing the gRNA sequence."},{"answer":"Restriction enzymes would be more efficient for editing multiple organisms","explanation":"Restriction enzymes cannot make single precise cuts needed for genome editing."}]},
    {"type":"MC","question":"Evaluate the statement: 'CRISPR-Cas9 has no limitations and is perfect for all genome editing applications.'","correct":"This is incorrect because CRISPR can have off-target effects at similar sequences, requires a PAM sequence near the target, and delivery to specific tissues remains challenging","correctExplanation":"While CRISPR is revolutionary, it has real limitations including off-target cutting, PAM requirements, and delivery challenges that restrict certain applications.","distractors":[{"answer":"The statement is correct because CRISPR is perfect in every application","explanation":"No technology is perfect; CRISPR has documented limitations."},{"answer":"The only limitation is that CRISPR cannot cut double-stranded DNA","explanation":"Cas9 specifically cuts both strands; the real limitations are off-target effects and delivery."},{"answer":"CRISPR's only limitation is its high cost","explanation":"CRISPR is actually cheap; its limitations are biological (off-target effects, PAM, delivery)."}]},
    {"type":"MC","question":"In early gene therapy trials, some patients developed leukaemia after viral vectors inserted near proto-oncogenes. Explain how CRISPR-Cas9 reduces this risk.","correct":"CRISPR targets a specific predetermined location, avoiding random insertion near proto-oncogenes that could activate them","correctExplanation":"By choosing the exact cut location, scientists avoid the dangerous random integration that activated cancer genes in earlier trials.","distractors":[{"answer":"CRISPR never causes any insertional mutations","explanation":"While CRISPR reduces random insertion risk, off-target effects can still occur at unintended locations."},{"answer":"CRISPR eliminates all cancer risk from gene therapy","explanation":"CRISPR reduces but does not eliminate risks; off-target effects could still affect important genes."},{"answer":"Viral vectors were more precise than CRISPR in these trials","explanation":"Viral integration was random, which is why it caused problems; CRISPR is more precise."}]},
    {"type":"MC","question":"A student asks why scientists don't simply use restriction enzymes for genome editing since they also cut DNA. Provide a detailed explanation.","correct":"Restriction enzymes cut at every matching site in the genome (potentially hundreds), cannot be retargeted to new sequences, and create unwanted cuts that would fragment the genome","correctExplanation":"Genome editing requires a single precise cut at one location. Restriction enzymes' short recognition sites and non-programmable nature make them unsuitable for this purpose.","distractors":[{"answer":"Restriction enzymes could be used for genome editing if the right one is chosen","explanation":"Even the best restriction enzyme has a recognition site that occurs too frequently for single-site editing."},{"answer":"Restriction enzymes are actually used for genome editing more often than CRISPR","explanation":"CRISPR has largely replaced restriction enzymes for targeted editing due to its programmability."},{"answer":"Restriction enzymes and CRISPR produce identical results","explanation":"Restriction enzymes make multiple cuts while CRISPR makes one targeted cut — very different outcomes."}]},
    {"type":"MC","question":"Calculate the approximate number of times a 6-nucleotide restriction enzyme site would appear in the 3 billion base pair human genome, and compare this to the expected frequency of a 20-nucleotide sequence.","correct":"A 6-nucleotide site appears roughly every 4096 bases (about 730,000 times), while a 20-nucleotide sequence would appear approximately once","correctExplanation":"4⁶ = 4096, so the site appears roughly every 4096 bp, giving ~730,000 sites in 3 billion bp. 4²⁰ ≈ 1.1 trillion, far exceeding the genome size, so a 20-mer appears roughly once.","distractors":[{"answer":"Both appear approximately the same number of times","explanation":"The exponential relationship means a 20-nucleotide sequence is astronomically rarer than a 6-nucleotide one."},{"answer":"A 6-nucleotide site appears only once and a 20-nucleotide sequence appears millions of times","explanation":"This is reversed; shorter sequences appear more frequently."},{"answer":"The length of the recognition sequence has no effect on frequency","explanation":"Frequency decreases exponentially with sequence length."}]},
    {"type":"MC","question":"Compare the workflow of designing a new CRISPR experiment versus a new TALEN experiment. Why is CRISPR faster to develop?","correct":"CRISPR requires only designing and synthesising a 20-nucleotide RNA sequence, while TALENs require designing, cloning and testing a custom protein for each new target","correctExplanation":"RNA synthesis is fast, cheap and straightforward, while protein engineering is complex, time-consuming and expensive, giving CRISPR a major workflow advantage.","distractors":[{"answer":"TALENs are faster because they use simpler components","explanation":"TALENs require complex protein engineering; CRISPR's RNA-based targeting is simpler."},{"answer":"Both methods take exactly the same time to develop","explanation":"CRISPR design takes days while TALEN design can take weeks to months."},{"answer":"CRISPR requires more steps than TALEN design","explanation":"CRISPR requires fewer steps because it uses RNA rather than custom proteins."}]},
    {"type":"Cloze","prompt":"Apply your understanding to compare the methods.","sentence":"CRISPR's advantage over restriction enzymes is its {{blank:1}}, while its advantage over ZFNs and TALENs is its {{blank:2}} and lower cost.","blanks":{"1":{"correct":"precision","correctExplanation":"The 20-nucleotide gRNA provides single-site precision that restriction enzymes cannot achieve.","distractors":[{"answer":"speed","explanation":"While CRISPR may be faster, the primary advantage over restriction enzymes is precision."},{"answer":"cost","explanation":"Cost is the advantage over ZFNs/TALENs; precision is the advantage over restriction enzymes."}]},"2":{"correct":"simplicity","correctExplanation":"Designing a new RNA sequence is much simpler than engineering custom proteins required by ZFNs and TALENs.","distractors":[{"answer":"complexity","explanation":"CRISPR's advantage is simplicity, not complexity."},{"answer":"precision","explanation":"Precision is similar between CRISPR and TALENs; simplicity and cost are CRISPR's main advantages over them."}]}}},
    {"type":"Cloze","prompt":"Apply your knowledge to the clinical context.","sentence":"In early gene therapy, random viral {{blank:1}} near proto-oncogenes caused cancer. CRISPR reduces this risk by targeting a {{blank:2}} predetermined location.","blanks":{"1":{"correct":"insertion","correctExplanation":"Viral vectors inserted genes at random locations, sometimes near cancer-promoting genes.","distractors":[{"answer":"deletion","explanation":"The problem was random insertion, not deletion, of genetic material."},{"answer":"amplification","explanation":"The issue was random insertion of the viral cargo near cancer genes."}]},"2":{"correct":"specific","correctExplanation":"CRISPR's gRNA-guided targeting ensures the edit occurs at a specific predetermined location, not randomly.","distractors":[{"answer":"random","explanation":"CRISPR's advantage is specific, not random, targeting."},{"answer":"multiple","explanation":"CRISPR aims for a single specific site, not multiple locations."}]}}},
    {"type":"Cloze","prompt":"Complete the sentence about exponential specificity.","sentence":"A 20-nucleotide gRNA has 4²⁰ (over one {{blank:1}}) possible sequence combinations, making it statistically likely to match only {{blank:2}} location in any genome.","blanks":{"1":{"correct":"trillion","correctExplanation":"4²⁰ = approximately 1.1 trillion possible sequences, far exceeding the size of any genome.","distractors":[{"answer":"thousand","explanation":"4²⁰ is over a trillion, not a thousand."},{"answer":"million","explanation":"4²⁰ is over a trillion, much larger than a million."}]},"2":{"correct":"one","correctExplanation":"With over a trillion possible combinations and a genome of only 3 billion bases, a 20-nucleotide sequence typically matches one site.","distractors":[{"answer":"hundreds","explanation":"The statistical analysis shows one match, not hundreds."},{"answer":"thousands","explanation":"A 20-nucleotide sequence is far too specific to match thousands of sites."}]}}}
  ],
  "toLevel5": [
    {"type":"MC","question":"Evaluate the trade-off between CRISPR's high precision and its potential for off-target effects. How can this apparent contradiction be explained?","correct":"While the 20-nucleotide gRNA provides high specificity, partial matches at similar sequences can still lead to off-target cutting, though at much lower rates than restriction enzymes","correctExplanation":"CRISPR is highly precise but not perfect. Sequences with only 1-3 mismatches can sometimes be cut, though this occurs far less frequently than the multiple cuts from restriction enzymes.","distractors":[{"answer":"Off-target effects prove that CRISPR is no better than restriction enzymes","explanation":"Off-target effects are rare; CRISPR is still vastly more precise than restriction enzymes."},{"answer":"CRISPR never has off-target effects","explanation":"Off-target effects are documented and represent a real limitation of the technology."},{"answer":"The contradiction cannot be explained scientifically","explanation":"The science of partial complementarity explains how rare off-target events occur despite high precision."}]},
    {"type":"MC","question":"Analyse why the development of CRISPR-Cas9 is considered one of the most significant biotechnology breakthroughs. Consider its impact across multiple fields.","correct":"CRISPR democratised genome editing by making it cheap, fast and simple enough for any lab to use, accelerating research in medicine, agriculture, ecology and basic biology","correctExplanation":"Before CRISPR, genome editing was expensive and required specialist expertise. CRISPR's accessibility transformed not just one field but many, from crop improvement to disease treatment.","distractors":[{"answer":"CRISPR is only significant for medical applications","explanation":"CRISPR has transformed agriculture, basic research, ecology and industrial biotechnology as well as medicine."},{"answer":"CRISPR is less significant than restriction enzyme discovery","explanation":"While restriction enzymes were important, CRISPR's programmability represents a greater leap in capability."},{"answer":"CRISPR has had no impact outside academic laboratories","explanation":"CRISPR has clinical, agricultural and industrial applications well beyond academia."}]},
    {"type":"MC","question":"Critique the argument that CRISPR should completely replace all restriction enzyme use in molecular biology.","correct":"Restriction enzymes remain essential for routine cloning, plasmid construction and DNA analysis; CRISPR excels specifically at targeted genome editing — they serve different purposes","correctExplanation":"Restriction enzymes and CRISPR are complementary tools. Restriction enzymes are still the standard for cutting DNA at known sites for cloning, while CRISPR is used for genome editing.","distractors":[{"answer":"The argument is correct; restriction enzymes are completely obsolete","explanation":"Restriction enzymes remain essential for cloning, diagnostic work and many standard molecular biology techniques."},{"answer":"CRISPR cannot be used for genome editing","explanation":"CRISPR is specifically designed for genome editing and has been used extensively for this purpose."},{"answer":"Restriction enzymes and CRISPR serve identical purposes","explanation":"They serve different purposes: restriction enzymes for routine DNA manipulation, CRISPR for targeted genome editing."}]},
    {"type":"MC","question":"Evaluate whether the precision advantage of CRISPR over restriction enzymes would be maintained if someone designed a restriction enzyme with a 20-nucleotide recognition site.","correct":"A hypothetical 20-nucleotide restriction enzyme would match CRISPR's precision but would still lack programmability — it could only cut one fixed sequence, while CRISPR can target any sequence","correctExplanation":"Even with equal precision, a restriction enzyme would be limited to one target. CRISPR's programmability through gRNA design is a separate advantage from its precision.","distractors":[{"answer":"Such a restriction enzyme would be superior to CRISPR in every way","explanation":"It would match precision but lack programmability, which is CRISPR's key advantage."},{"answer":"A 20-nucleotide restriction enzyme is impossible to create","explanation":"While challenging, the question addresses the theoretical comparison of precision versus programmability."},{"answer":"Precision and programmability are the same advantage","explanation":"They are distinct: precision relates to targeting specificity, programmability relates to ease of retargeting."}]},
    {"type":"MC","question":"Analyse how the cost reduction from ZFNs/TALENs to CRISPR has affected the ethical landscape of genome editing.","correct":"Cheaper technology means more labs and countries can access genome editing, raising concerns about regulation, oversight and potential misuse in settings with less governance","correctExplanation":"Accessibility creates both benefits (wider research) and concerns (harder to regulate). As genome editing becomes ubiquitous, ensuring responsible use becomes more challenging.","distractors":[{"answer":"Lower cost has no effect on the ethical landscape","explanation":"Cost directly affects who can access the technology, which has significant ethical implications."},{"answer":"Cheaper technology always leads to more ethical use","explanation":"Wider accessibility can also lead to less oversight and potential misuse."},{"answer":"Only expensive technologies raise ethical concerns","explanation":"Cheap, accessible technologies raise unique ethical concerns about regulation and misuse."}]},
    {"type":"MC","question":"Compare the specificity mechanisms of CRISPR (RNA-DNA base pairing) and restriction enzymes (protein-DNA recognition). Evaluate which mechanism is inherently more flexible.","correct":"RNA-DNA base pairing is more flexible because any RNA sequence can be synthesised quickly, while protein-DNA recognition requires complex structural engineering to change targets","correctExplanation":"RNA synthesis follows simple rules of complementarity and can be done in hours. Engineering proteins to recognise new DNA sequences requires extensive structural analysis and testing.","distractors":[{"answer":"Protein-DNA recognition is more flexible because proteins are more complex","explanation":"Complexity makes protein engineering harder, not more flexible."},{"answer":"Both mechanisms are equally flexible","explanation":"RNA design is far simpler and faster than protein engineering."},{"answer":"Neither mechanism can be modified for new targets","explanation":"Both can be modified, but RNA-based targeting is dramatically easier."}]},
    {"type":"MC","question":"Predict how the advantages of CRISPR-Cas9 might change as newer versions of the technology are developed.","correct":"Improved Cas9 variants with reduced off-target effects and relaxed PAM requirements would further widen the gap between CRISPR and older methods","correctExplanation":"Active research is producing high-fidelity Cas9 variants and PAM-less versions, which would address current limitations while maintaining CRISPR's cost and simplicity advantages.","distractors":[{"answer":"Future improvements will make restriction enzymes more precise than CRISPR","explanation":"Improvements to CRISPR will widen its advantage, not reduce it."},{"answer":"CRISPR technology cannot be improved further","explanation":"Active research continues to improve Cas9 fidelity and expand targeting capabilities."},{"answer":"Older methods will surpass CRISPR as technology progresses","explanation":"CRISPR improvements are likely to maintain and extend its advantages."}]},
    {"type":"MC","question":"Evaluate the significance of CRISPR being described as 'molecular scissors' compared to restriction enzymes also being called 'molecular scissors'. Are both descriptions equally appropriate?","correct":"Both cut DNA, but CRISPR is 'programmable scissors' that can be directed anywhere, while restriction enzymes are 'fixed scissors' that only cut at predetermined sites — the descriptions oversimplify the critical difference","correctExplanation":"The 'molecular scissors' metaphor captures the cutting function but misses the crucial distinction of programmability versus fixed targeting.","distractors":[{"answer":"Both are equally precise molecular scissors with no functional difference","explanation":"The programmability difference is fundamental and the metaphor obscures it."},{"answer":"Only restriction enzymes should be called molecular scissors","explanation":"Both cut DNA; the distinction is in how they are targeted."},{"answer":"Neither should be called molecular scissors because they are enzymes","explanation":"The metaphor is useful for conveying the concept of DNA cutting, but needs qualification about programmability."}]}
  ]
}
